NDA 084779 describes ORPHENADRINE CITRATE, which is a drug marketed by
Hikma,
Rising,
Sagent Pharms,
Watson Labs,
Ascot,
Bayshore Pharms Llc,
Lupin,
Sandoz, and
Stevens J, and is included in fifteen NDAs. It is available from
twenty suppliers. Additional details are available on the
ORPHENADRINE CITRATE profile page.
The generic ingredient in ORPHENADRINE CITRATE is
aspirin; caffeine; orphenadrine citrate. There are twenty-two
drug master file entries for this compound. Three
suppliers are listed for this compound. Additional details are available on the
aspirin; caffeine; orphenadrine citrate profile page.